https://tissuepathology.com/2014/11/04/breaking-news-medimmune-strengthens-immuno-oncology-capabilities-with-acquisition-of-definiens/ Educational and informative Wed, 06 Jul 2016 11:25:36 +0000 hourly 1 https://tissuepathology.com/2014/11/04/breaking-news-medimmune-strengthens-immuno-oncology-capabilities-with-acquisition-of-definiens/#comment-141299 Wed, 06 Jul 2016 11:25:36 +0000 http://tissuepathology.com/?p=7473#comment-141299 […] If you were looking for some major milestone events indicating the level of interest in digital pathology, you could focus on last week when Philips acquired tumor analysis business PathXL, based in Belfast, Northern Ireland. A couple of years ago, AstraZeneca’s global biologics research and development arm, MedImmune, acquired Definiens in a $150 million deal. […]

]]>